AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
MD Anderson Cancer specialists hopeful of new era of cancer vaccine therapy.(Cancer Immunology Research facility)
Researchers at the USA-based University of Texas' MD Anderson Cancer Center say that in-house clinical trials of their cancer vaccines are producing "very promising results" in difficult-to-treat indications such as advanced myeloid leukemia, glioblastoma multiforme, aggressive lymphoma and melanoma.
In 2003, the MD Anderson Center opened its Cancer Immunology Research facility, which is believed to be the first comprehensive program in the USA uniting both basic and clinical immunologists in open laboratory environments to develop immunological treatments for cancer. Now, just a few year later, several of the Center's vaccines have shown strong anti-tumor activity and one has produced the first clinical demonstration that a vaccine could produce complete molecular remission.
…
- AVAX Technologies Becomes First Company to Commercialize Individualized Cancer...
- Press release article from: PR Newswire July 18, 2000 700+ words
...today announced that its autologous cancer vaccine (AC Vaccine(TM)) for melanoma...time a centrally produced autologous cancer vaccine for melanoma, custom-made from the...quest has always been to develop a cancer vaccine with therapeutic potential that is...
- Results of Antigenics' Cancer Vaccine in Two Clinical Trials Presented at ASCO.
- Press release article from: PR Newswire May 22, 2000 700+ words
...carcinoma from two separate trials with its personalized cancer vaccine, Oncophage(R), at the 36th Annual Meeting of the American...20000419/NYW038 ) Dr. Robert J. Amato and colleagues at the MD Anderson Cancer Center in Houston presented preliminary results from...
- Data from Biomira's Patient-Specific Cancer Vaccine to be Presented at 2004...
- Press release article from: PR Newswire November 9, 2004 700+ words
...ASH) in San Diego. Sattva S. Neelapu, M.D., of the MD Anderson Cancer Center in Houston, TX, is to present the data...and novel strategies for cancer immunotherapy. We are The Cancer Vaccine People(TM). This release may contain forward-looking...
- Norwood Immunology - Phase II clinical trial - melanoma cancer vaccine; first...
- News wire article from: Chemical Business Newsbase November 17, 2005 700+ words
...undertaken in collaboration with The University of Texas MD Anderson Cancer Center, of Houston. The first of the 100 patients...an enhanced immune response to an investigational melanoma cancer vaccine, as a result of using the company's technology as an adjuvant...
- Data on Antigenics Autologous Cancer Vaccine Presented at American Society of...
- Press release article from: PR Newswire May 18, 1999 700+ words
Researchers From MD Anderson, Memorial Sloan-Kettering Announce Results of Trials With Patient...O., Deputy Chairman and Associate Center Medical Director at MD Anderson Cancer Center. The purpose of the 42 patient trial was to determine...
- Anti-Cancer Vaccine Doubles Time-To-Disease Progression and Increases Survival...
- Press release article from: PR Newswire November 19, 2004 700+ words
...immunostimulatory molecule. The glioma vaccine is currently in Phase II trials being conducted by Duke University and the MD Anderson Cancer Center under a grant from the National Institutes of Health. The current version of the vaccine includes the EGFRvIII...
- Dallas Researchers' Lung-Cancer Vaccine Shows Promise.
- Newspaper article from: Knight Ridder/Tribune Business News February 19, 2004 700+ words
...study are promising, but larger, randomized trials are needed, said Dr. Roy Herbst, chief of thoracic medical oncology at MD Anderson Cancer Center in Houston. "For an initial approach, I think it's a good first step," he said. But it has its limitations...
- AVAX Technologies' O-Vax(TM) Cancer Vaccine Induces Positive Immunological and...
- Press release article from: PR Newswire May 22, 2000 700+ words
...currently working with the University of Tokyo on studying the application of the technology to breast cancer, and with the MD Anderson Cancer Center with application to acute myelogenous leukemia. Our intention has always been to use the AC Vaccine technology...
- AVANT Immunotherapeutics Announces Hart-Scott Rodino Clearance to License...
- Press release article from: PR Newswire May 21, 2008 700+ words
...John Sampson and his colleagues at the Duke University Brain Tumor Center in collaboration with Dr. Amy Heimberger at the MD Anderson Cancer Center. AVANT has several other product candidates in its development pipeline including: -- CDX-1307, a product...
- Lung Cancer Vaccine Data Encouraging.
- Newspaper article from: Cell Therapy News March 1, 2003 700+ words
...I/II clinical trial of GVAX lung cancer vaccine, a patient-specific vaccine made...following treatment with GVAX lung cancer vaccine. In addition, two patients continue...may be more responsive to GVAX lung cancer vaccine. Five additional patients were reported...
Source: HighBeam Research, MD Anderson Cancer specialists hopeful of new era of cancer vaccine...
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA
The AccessMyLibrary advertising network includes:
